STUDY OBJECTIVE As delirium is a common manifestation in critically ill patients and is associated with worse clinical outcomes, we sought to characterize the reversibility of delirium after discontinuation of sedation and to determine whether sedation-associated delirium that rapidly reverses impacts clinical outcomes. DESIGN Post hoc subgroup analysis of prospectively collected data from a previously published study. PATIENTS Seventy adults admitted to a medical intensive care unit (ICU) between March and July 2012 who required mechanical ventilation with continuous analgesia and/or sedation and underwent a spontaneous awakening trial (SAT). MEASUREMENTS AND MAIN RESULTS Patients were grouped into four categories: delirium free, rapidly reversible delirium (RRD; defined as delirium always resolving within 4 hrs of stopping sedatives), persistent delirium (PD; defined as delirium always persisting for ≥ 4 hours after stopping sedatives), or mixed delirium (consisting of RRD and PD episodes). The incidence of the four delirium subtypes and their associations with clinical outcomes were evaluated. A validated, guideline-recommended, bedside delirium monitoring instrument-the Confusion Assessment Method for the ICU (CAM-ICU)-was used to assess for the presence or absence of delirium. Clinical outcomes included ventilator-free days at day 28, ICU and hospital length of stay, 28-day mortality, and patient disposition; time to first CAM-ICU becoming negative (delirium free) for a continuous 48-hour duration was also assessed. A total of 103 SATs were performed in the 70 patients. Of the 103 SATs, 28 (27.2%) were CAM-ICU negative before the SAT. Of the remaining 75 SATs, PD was present for the majority of SATs (62 [82.7%]); RRD was present after 13 (17.3%) SATs. On a patient level, 17 patients (24.3%) were always delirium free before cessation of medications for continuous sedation. Of the 53 patients with delirium before undergoing an SAT, 11 (20.8%) had RRD, 2 (3.8%) had mixed delirium, and 40 (75.5%) had PD. Proportional odds logistic regression adjusting for age, Acute Physiology and Chronic Health Evaluation II score, sepsis, and preexisting hypertension showed that patients with PD had a higher probability of longer ICU length of stay (odds ratio 4.01 [95% confidence interval 1.36-11.77], p=0.011), but those with RRD did not.
Delirium is a common manifestation of brain organ dysfunction that occurs in up to 80% of mechanically ventilated patients and is characterized by the acute onset and fluctuating nature of an altered level of consciousness and cognition. 1, 2 Furthermore, delirium is a strong predictor of poor clinical outcomes including longterm cognitive impairment, prolonged length of stay, and increased mortality. 1, [3] [4] [5] Although the pathophysiology of delirium is not fully understood, risk factors for its development are multifactorial and include a higher severity of acute illness and chronic health conditions such as dementia and hypertension. 6 Oversedation and use of sedatives including benzodiazepines are also known risk factors for delirium. 6, 7 Consequently, spontaneous awakening trials (SATs), or protocolized cessation of sedative medications, have become part of a bundled approach to prevent oversedation, prolonged time on mechanical ventilation, and delirium. 8, 9 Even with sedation-minimization strategies, the pharmacologic effects of sedative and analgesic medications may persist due to decreased clearance. 10 Recently, it has been demonstrated that in a small subset of patients, delirium rapidly abated following an SAT, and this sedation-related, rapidly reversible delirium may portend similar outcomes to those patients who were always delirium-free. 11 However, delirium still persisted in the vast majority of these patients after cessation of sedative medications and was associated with poor long-term outcomes.
Multiple factors, including the fluctuating nature of delirium, must be taken into account when trying to understand the reversal or persistence of sedative-associated delirium. In addition, it is unclear if and how long sedativeassociated delirium persists following discontinuation of sedatives. Therefore, the goal of this study was to characterize the effect of sedation on delirium and the subsequent impact on clinical outcomes.
Methods

Study Design and Participants
This post hoc study of prospectively collected data was approved by the Vanderbilt University Medical Center Investigational Review Board (Nashville, TN). Patient data included in this study were from a previously published study that demonstrated the effectiveness of a pharmacist-driven Awakening Breathing and Coordination Quality Improvement program. 12 Patients were included in this study if they required continuous analgesia and/or sedation while receiving mechanical ventilation and had an SAT conducted after passing a safety screen in the adult medical intensive care unit (ICU) between March and July 2012. Safety screen exclusion criteria included fraction of inspired oxygen > 70% or oxygen saturation < 88%, ongoing agitation (Richmond Agitation Severity Scale [RASS] ≥ +2 within the last 4 hrs), sedation for seizures, paralysis, ordered RASS score À4 or À5, increased intracranial pressure (> 20 mm Hg), active myocardial infarction (troponin level > 0.2 lg/L), or comfort measures only. The institution's sedation protocol promoted a light level of arousal (RASS score 0 to À2) with providers electronically prompted daily to order a goal RASS score for each patient. A validated, guideline-recommended, bedside delirium monitoring instrument-the Confusion Assessment Method for the ICU (CAM-ICU)-was used to assess for the presence or absence for delirium. Patients were excluded if they were CAM-ICU "unable to assess" (RASS score À4 to À5 [i.e., comatose]) for both assessments before SAT. In addition, patients received paired SATs and spontaneous breathing trials (SBTs) as part of a bundled approach, along with protocolized ventilator weaning and delirium and early mobility management in the ICU, in order to improve patient outcomes. 8 As in the Awakening and Breathing Coordination (ABC) study, during an SAT, all continuous analgesia and sedation was stopped, but patients could receive up to three doses of intermittent analgesia if needed. 8 If patients passed their SAT, they remained off of continuous analgesia and sedation. The institution's protocol required that patients receive three intermittent doses of analgesia before restarting continuous analgesia and sedation.
Data Collection
Patient information, including sedative, analgesic, and antipsychotic medication use as well as antibiotics, vasoactive medications, and corticosteroid requirements, were assessed during the calendar day before each SAT. The presence of acute kidney injury, defined as an increase in serum creatinine concentration > 1.5 times the baseline value or urine output < 0.5 ml/kg/hour for 6 hours, and liver dysfunction, defined as total bilirubin level > 2.0 mg/dl and either alkaline phosphatase or a transaminase level greater than twice the upper limit of normal, were assessed in the calendar day before each SAT. 13, 14 Delirium Classification RASS and CAM-ICU status were assessed every 4 hours by the bedside nurse throughout the entire study period, including pre-SAT and 4 hours later, post-SAT. Due to the fluctuating nature of delirium, patients were defined as CAM-ICU positive before SAT if at least one of the two CAM-ICU assessments before SAT were positive. On a per-SAT basis, patients were classified into one of three groups: normal (delirium free and not comatose) before SAT; rapidly reversible delirium (RRD), defined as CAM-ICU positive before SAT and becoming CAM-ICU negative within 4 hours of sedation cessation; and persistent delirium (PD), defined as CAM-ICU positive before SAT and remaining CAM-ICU positive for ≥ 4 hours after sedation cessation. On a per-patient level, patients were classified into one of four groups, taking into account each SAT: always normal (delirium free); always RRD; mixed delirium, defined as the occurrence of both RRD and PD; or always PD (no episodes of being normal before SAT or having RRD).
Clinical Outcomes
The incidence of the four delirium subtypes (delirium free, RRD, mixed delirium, and PD) at a patient level and their associations with clinical outcomes were evaluated. Clinical outcomes included ventilator-free days at day 28, ICU and hospital length of stay (LOS), 28-day mortality, and patient disposition. Due to the fluctuating nature of delirium, time to first CAM-ICU becoming negative after SAT, as well as time to first CAM-ICU becoming negative for a continuous 48-hour period after SAT, were evaluated. Because patients had their first SAT screen on variable days of their ICU stay, ICU and hospital LOS was defined as the time from the first SAT until the end of the ICU or hospital stay, respectively.
Statistical Analysis
Categorical data were analyzed by using v 2 tests, and continuous data were analyzed by using the Kruskal-Wallis test. We used proportional odds logistic regression models to study the association between the delirium subtypes and outcomes including ventilator-free days and ICU and hospital LOS, and logistic regression for 28-day mortality, adjusting for known delirium confounders, determined a priori, which included age, Acute Physiology and Chronic Health Evaluation II score, sepsis, and preexisting hypertension. Patients were censored at death or hospital discharge. All study data were collected using an electronic data capture tool hosted at Vanderbilt University (REDCap [project-redcap.org]). 15 Statistical analyses were performed by using R software, version 3.1.2 (R Foundation for Statistical Computing, Vienna, Austria [www.r-project.org]).
Results
Between March and July 2012, 219 patients were included in the analysis, contributing 580 mechanical ventilator days ( Figure 1 At a patient level taking into account all SATs performed for the 70 patients, 17 [24.3%] patients were always delirium free before cessation of their sedative medications (Figure 2) . Of the 53 patients with any delirium before SAT, 11 (20.8%) patients had delirium that was always rapidly reversible (RRD), 2 (3.8%) had mixed delirium, and 40 (75.5%) had PD after every SAT.
Baseline characteristics of the patients included in the analysis are shown in Table 1 . Of the 103 SATs assessed, acute kidney injury occurred in 11 (39%) of the delirium-free group, 11 (39%) of the RRD group, and in 3 (52%) of the PD group. Of the 103 SATs assessed, liver dysfunction occurred in 5 (18%) of the delirium-free group, 2 (15%) of the RRD group, and in 18 (29%) of the PD group. Medication exposure in the calendar day before each SAT is shown in Table 2 . SATs that were not passed required reinitiation of sedation during the 2-hour trial. Of the 88 (85.4%) SATs that were passed, reinitiation of sedation was required in 20, with a median (IQR) time from the end of the passed SAT until sedation reinitiation of 5.5 (2.75-8.5) hours. Of those who passed their SAT, sedation was restarted within 2 hours post-SAT in two patients who both required procedural sedation. Clinical outcomes at a per-patient level are shown in Table 3 , with patients with mixed delirium or PD showing a greater time to becoming CAM-ICU negative for 48 hours compared with those patients with no delirium or RRD.
In the multivariable regressions, no significant differences were seen between patients with RRD or mixed delirium/PD when compared with those patients who were delirium free with regard to ventilator-free days and 28-day mortality outcomes (Table 4) . Patients with mixed delirium or PD had a higher probability of longer ICU (p=0.011) and hospital (p=0.053) LOS compared to patients who were delirium free (Table 4) ; however, patients with RRD had outcomes similar to those who were delirium free (Table 4) . 
Discussion
In this analysis of critically ill medical ICU patients, delirium was found to be present in three of every four patients who were mechanically ventilated and receiving continuous analgesia and/or sedation, and this delirium still persisted in a majority of patients for an extended duration despite cessation of sedative medications. Patients' delirium rapidly resolved with the removal of sedation in < 20% of all SATs performed. When patients were CAM-ICU positive Represents median dose (interquartile range) in the calendar day before each SAT among those exposed to that medication that day.
c Hydromorphone administered to one patient (Delirium Free); interquartile range cannot be calculated. before SAT, delirium persisted for ≥ 4 hours in 82.7% of assessments. This underscores the importance that sedation-associated delirium is not a transient phenomenon that can be ignored.
Patients with PD had a higher probability of longer ICU LOS compared to patients with RRD or those who were always delirium free. There were no significant differences in other outcomes assessed. One group 11 sought to differentiate rapidly reversible sedation-related delirium from other types of delirium in 102 medial ICU patients. In their prospective, observational, blinded study, only a small proportion (12%) of patients were identified with delirium that resolved within 2 hours of sedation cessation. The study demonstrated that these patients behaved similarly to those without delirium in terms of clinical outcomes; however, the vast majority of patients had delirium that persisted beyond 2 hours from their SAT. Our study corroborated these findings and expanded on it by demonstrating that even after 4 hours of stopping sedation, only a small subset (20%) of patients rapidly reversed their delirium, whereas the majority stayed persistently delirious; a median (IQR) of 50.6 (12.8-76.0) hours was required for these patients to first become delirium free for a continuous 48 hours.
This group 11 found that patients with PD had a 66% 1-year mortality compared with 20% for those with RRD, similar to those without delirium. This is in contrast to our findings where the only significant difference in outcomes we observed was an increase in ICU LOS for patients with PD, but not RRD, compared with those without delirium. We found no significant differences in ventilator-free days or mortality, although our mortality outcome was limited to 28 days. One must also realize, however, that studies thus far have been tremendously underpowered to determine true differences between patients with RRD and those with no delirium. If we simulate the mortality outcome and expect an estimated 12% mortality among delirium-free patients, with a ratio of RRD to delirium-free patients of 0.65, then to have 80% power to detect a 5%, 10%, or 15% difference in absolute mortality between rapidly reversible patients and those who are delirium free, one would need to enroll 4226, 1235, or 622 patients, respectively. Thus, one needs to be cautious in interpretation of the relative harmless nature of RRD, in comparison to PD, because as such, the studies have not been designed to be able to show a difference in mortality.
The differences in outcomes in the two studies could be also related to differences in the depth of sedation. In one study, 11 patients with delirium were found to have a deeper level of sedation than those without delirium (RASS À2 vs 0, respectively) before, as well as after, their daily sedation interruption (RASS À1 vs 0, respectively). Given the fact that sedatives can persist in the body for a significant duration in the critically ill, and patients with PD were found to be at a deeper level of sedation at their 2-hour assessment than those with RRD, it is possible that (over)sedation played a significant role on the negative outcomes seen in this population. This contrasts with the present study where before SAT, patients with PD had a median RASS of 1, compared to À1 for those with RRD, and 0 for those without delirium. Another study also demonstrated that patients not only continued to remain moderately sedated for up to 2 hours despite removal of sedative medications (23% at RASS À2 to À3), but those at a deeper level of sedation had an increased incidence of delirium, irrespective of the delirium screening instrument used. 16 However, 20% and 32% of the patients in their study received continuous and intermittent sedation with midazolam, respectively, which may have been responsible for the delayed awakening that was seen. Due to the pharmacokinetic effects of midazolam, when used in critically ill patients, especially those with altered volumes of distribution or with altered hepatic or renal function, prolonged sedation will likely ensue. 10 Since delirium, by its diagnostic criteria, is of an acute fluctuating nature, 2 paired CAM-ICU and RASS assessments were performed every 4 hours, which aims to provide an understanding of a patient's acute brain dysfunction throughout the course of their critical illness. The present study assessed not only the time to first becoming delirium free but also determined the time until the resolution of the fluctuating syndrome by identifying the time to becoming persistently delirium free over a continuous 48-hour period. Future work is needed to more fully elucidate the relationship between time to first delirium-free incidence versus becoming delirium free for an extended period of time. Due to the delayed awakening after utilization of not only benzodiazepines but other sedative medications, 17 frequent and continued monitoring of patients' sedation and delirium status is warranted and should be part of regular interdisciplinary discussions of patients care. 18 Although the CAM-ICU was validated using RASS À4 and À5 (arousal only to touch, not voice) as thresholds for the inability to assess or perform the test, it has been recently suggested that the degree of arousal seen at a RASS À3 (movement or eye opening without eye contact to verbal stimuli) will more likely result in a CAM-ICU-positive assessment than at a RASS > À3. 16, 19 Although the present study used the original CAM-ICU validation criteria defining coma as RASS À4 and À5, RASS À3 was seen in 19 patients before SAT; all were CAM-ICU positive before SAT, and all but one exhibited PD after their SAT. Our findings support this suggestion; however, further work is needed to definitively elucidate this relationship.
An important limitation of this study was the inability to control for all potential causes, risk factors, or treatment effects of delirium. Despite the information collected regarding some factors commonly associated with delirium, it is difficult to assess all predisposing or precipitating risk factors, as well as nonpharmacologic treatment and prevention strategies that may alter the results. 20, 21 However, all sedative and analgesic medication exposure, including continuous-infusion and bolus administration, as well as antipsychotic medication administration, was determined over the 24 hours before each SAT from the medication administration record. In addition, other medications that have been associated with delirium or a higher severity of illness were analyzed including corticosteroids, antibiotics, and vasoactive medications. Acute and chronic organ dysfunction, which may significantly result in the accumulation and delayed clearance of harmful medications, was assessed and addresses a limitation of previous studies. 10 A second limitation of this study is its lack of long-term follow-up after hospital discharge. Although 28-day mortality data were collected, long-term clinical outcomes, which have been associated with delirium, were not assessed. 1 Further large, well-designed studies are needed to determine the long-term impact of the timing of delirium resolution. A third limitation is that 47 of the 150 SATs examined over 580 mechanical ventilator days were excluded when the presence or absence of delirium was not able to be determined before the SAT (CAM-ICU "unable to assess" due to RASS À4 or À5). This deep level of sedation may result from sedative medications, but often the patient's underlying illness may contribute to this. In comparison, another study 11 did not analyze data from only 5 of its 102 enrolled patients due to RASS À4 to À5, but 69 patients with dementia or central nervous system disease, as well as 28 post-cardiac arrest patients, were excluded from enrollment in the study; however, both of these patient populations were included in the present study and may account for the difference seen in the number of comatose patients. Although determining if a patient's level of sedation is due to medications versus underlying illness is likely important, it is often difficult to differentiate in practice. In addition, the effects of any sedating medications given during or after SAT were not accounted for in the results and could potentially influence post-SAT CAM-ICU and RASS assessment. However, the effect of any medication given during this time period likely has minimal impact on CAM-ICU or RASS assessments. As stated in the Methods section, patients were maintained with a protocolized sedation-minimization and ventilator weaning/extubation strategy throughout their critical illness. Patients could receive up to three doses of intermittent analgesia during the SAT before being restarted on continuous sedation. Only two of the patients who passed their SAT required reinitiation on continuous sedation. Patients who did not pass their SAT were still kept at a light level of sedation after SAT, where additional medication administration likely did not impact study results. Finally, nearly half of the ventilator days were excluded due to lack of continuous sedation (i.e., only intermittent boluses were required). The patients contributing to these ventilator days were excluded since a SAT could not be conducted, but this illustrates the ability to reduce the utilization of continuous infusions in clinical practice.
Conclusion
Delirium is common in mechanically ventilated, critically ill patients and persists in a majority of these patients despite cessation of sedative medications. No significant differences in clinical outcomes were demonstrated among patients with the four defined delirium subtypes except for increased time in the ICU for those with PD. Care of critically ill patients should continue to focus on multimodal prevention and treatment of delirium, including sedation minimization.
